Vaccine Implementation Project
AIM's Vaccine Implementation Project aims to improve readiness and implementation of new immunization products and changes to existing recommendations in the U.S.
AIM's Vaccine Implementation Project aims to improve readiness and implementation of new immunization products and changes to existing recommendations in the U.S.
This AIM poster was displayed at the 2026 NAIIS Meeting and examines partner engagement to implement vaccine recommendations.
This AIM poster was displayed at the 2026 NAIIS Meeting and highlights a portion of the results from the 2025 AIM Annual Survey.
View the 2025 AIM Annual Survey Aggregate Report. The response rate for 2025 was 96% with 63 of 66 IPs completing the survey.
Find resources on AIM's 2025 Annual Survey, including a webinar focused on unpacking survey insights and a snapshot with high-level visual information.
The 2025 AIM Annual Survey Snapshot is a high-level overview of the results of the 2025 Annual Survey. The snapshot contains easy-to-read data.
In AIM’s first collaborative article with CDC, this manuscript highlights state and local practices optimizing the pediatric COVID-19 vaccination program.
This tip sheet provides a list of actionable solutions to challenges IPs and partners may face in increasing equitable access to birth dose immunizations.
AIM conducted listening sessions to gather lessons learned from the pediatric COVID-19 vaccine roll-out for children ages 5-11.